Research on the improvement effect of extracorporeal shock wave for spasticity

JRCT ID: jRCTs052220188

Registered date:09/03/2023

Basic Information

• Recruitment status: Recruiting
• Health condition(s) or Problem(s) studied: central nervous disorder (cerebral palsy, cerebral hemorrhage, cerebral infarction, acute encephalop
• Date of first enrollment: 18/03/2023
• Target sample size: 83
• Study type: Interventional
• Intervention(s): The extracorporeal shock wave therapy on the spastic muscle of upper and lower extremity

Outcome(s)

• Primary Outcome: Range of Motion, Modified Ashworth Scale

Key inclusion & exclusion criteria

• Age minimum: >= 2age old
• Age maximum: Not applicable
• Gender: Both

Include criteria

1. Spasticity in upper and lower extremity muscles in central nervous disorder
2. No orthopedic surgery, botulinum treatment, baclofen intrathecal treatment within the past 6 months
3. Written informed consent

Exclude criteria

1. Oral anticoagulant
2. Patients with untreated blood clotting disorders such as hemophilia
3. patients with thrombosis
4. patients with malignant tumors
5.Patients who have received cortisone therapy for more than 6 months or who have not passed 6 weeks since their last cortisone injection.
6. Patients who are pregnant or may be pregnant
7. jRCTs052190050 Research collaborators excluding completed cases who have completed up to follow-up in "research on improvement effect of spasticity by extracorporeal shock wave"
8. Other patients who are judged by the attending physician to be inappropriate for participation in this clinical study

Related Information

• Primary Sponsor: Hidehiko Kawabata